ࡱ> %'$%`  bjbjٕ . """""""\   (>&        $J h 9 "  9 ""N  ""  ""  @S   d 0 D D ,D" 20b" 2229 9 222 DDDD6JX"""""" Innovation in Phase I Clinical Development Practical approaches to phase I trial development in order to enable faster go / no-go decisions, reduce cost and speed time to market 20 - 22 September, 2010, Marriott Hotel, Munich, Germany Web:  HYPERLINK "https://owa.iqpc.co.uk/exchweb/bin/redir.asp?URL=http://www.phase1clinicaldevelopment.com/" \o "http://www.phase1clinicaldevelopment.com/" \t "_blank" www.phase1clinicaldevelopment.com (please use the following link as it contains the tracking code: http://bit.ly/cdHyVt) Email:  HYPERLINK "mailto:enquire@iqpc.co.uk" \o "mailto:enquire@iqpc.co.uk" \t "_blank" enquire@iqpc.co.uk Tel: +44 207 368 9300 Pharma IQ is pleased to announce the dates for the Innovation in Phase I Clinical Development conference taking place on 21st and 22nd September 2010. With the focus on cost control more important than ever, phase I clinical trials are becoming an increasingly crucial cog in the drug development process as the bid to save time and money has spurred innovation in trial design and processes at all levels. Investment in phase I has the potential to reduce overall costs by enabling faster go/no go decisions, which is why 40% of trials are now in phase I and the pressure is on to deliver results at an early stage. The Innovation in Phase I Clinical Development conference offers the opportunity to discover new methodologies, cost saving strategies and clarify changes to the regulatory landscape in a bid to reach proof of concept and make go/no go decisions as soon as possible. *+     k l ~   :  濨濨&hf>*B*CJOJQJ^JaJphhf0JCJOJQJ^JaJ,jhfB* CJOJQJU^JaJph#hfB* CJOJQJ^JaJph)hf6B* CJOJQJ]^JaJphhf)hf5B* CJOJQJ\^JaJph%+  gdf  ,1h. A!"#$% @@@ NormalCJ_HaJmH sH tH DA@D Default Paragraph FontRi@R  Table Normal4 l4a (k@(No List4U`4 f Hyperlink >*phFV@F PhFollowedHyperlink >*B* ph  "& + r v:r v:r v:r v:r v:r v:r v:r v: r v:r + 0000000000+ J0J0J0J0J0J0H0H0H0 0      k~ XX _Hlt264619442 _Hlt264619443@@p3[q36r3T7B*urn:schemas-microsoft-com:office:smarttagscountry-region8*urn:schemas-microsoft-com:office:smarttagsCity9*urn:schemas-microsoft-com:office:smarttagsplace P]hm:  "_@` " Phf@   d   0@UnknownGz Times New Roman5Symbol3& z Arial"qh榓& & !24  3HP)?f2*Innovation in Phase I Clinical DevelopmentImageImageOh+'0 , L X dpx,Innovation in Phase I Clinical DevelopmentImageNormalImage1Microsoft Office Word@q@0@9I&՜.+,D՜.+,\ hp  IQPC  ' +Innovation in Phase I Clinical Development Title 8@ _PID_HLINKSAX <Wmailto:enquire@iqpc.co.uk=z[https://owa.iqpc.co.uk/exchweb/bin/redir.asp?URL=http://www.phase1clinicaldevelopment.com/  !"#&Root Entry F 'S(1Table WordDocument.SummaryInformation(DocumentSummaryInformation8CompObjq  FMicrosoft Office Word Document MSWordDocWord.Document.89q